Adverse Reactions to Spironolactone: A Report From the Boston Collaborative Drug Surveillance Program

JAMA: The Journal of the American Medical Association

Volumn 225, Issue 1, 1973, Pages 40-43

  Greenblatt, David J ^a   Koch Weser, Jan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHLORIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; COMA; CONGESTIVE HEART FAILURE; DEHYDRATION; DIARRHEA; FEMALE; GYNECOMASTIA; HEADACHE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPONATREMIA; IATROGENIC DISEASE; LIVER CIRRHOSIS; MALE; NAUSEA; NEOPLASM; SKIN DISEASE; UREA NITROGEN BLOOD LEVEL; VOMITING;

ADULT; AGED; BLOOD UREA NITROGEN; COMA; DEHYDRATION; DIARRHEA; FEMALE; GYNECOMASTIA; HEADACHE; HEART FAILURE, CONGESTIVE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPONATREMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGE; NAUSEA; NEOPLASMS; POTASSIUM CHLORIDE; SKIN DISEASES; SPIRONOLACTONE; VOMITING;

EID: 0015912489     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1973.03220280028007     Document Type: Article

References (22)

1. Slone D, et al: Drug surveillance utilizing nurse monitors: An epidemiological approach. Lancet 2:901-903, 1966.
2. Borda IT, Slone D, Jick H: Assessment of adverse reactions within a drug surveillance program. JAMA 205:645-647, 1968.
3. Slone D, et al: Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep 84:39-52, 1969.
4. Jick H, et al: Comprehensive drug surveillance. JAMA 213:1455-1460, 1970.
5. Ross EJ: Aldosterone and its antagonists. Clin Pharmacol Ther 6:65-106, 1965.
6. Singer MM, DeGraff AC: Diuretic therapy: Part VII. Spironolactone. Am Heart J 68:835-837, 1964.
7. Liddle GW: Aldosterone antagonists and triamterine. Ann NY Acad Sci 139:466-470, 1966.
8. Seller RH, et al: Aldosterone antagonists in diuretic therapy. Arch Intern Med 113:350-355, 1964.
9. Eggert RC: Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J 4:401-403, 1970.
10. Gold H, et al: Spironolactone in regimens of pseudointractable edema of heart failure. J Clin Pharmacol 11:125-134, 1971.
11. Winer BM, Lubbe WF, Colton TW: Anti-hypertensive actions of diuretics: Comparative study of an aldosterone antagonist and a thiazide, alone and together. JAMA 204:775-779, 1968.
12. Johnson LC, Grieble HG: Treatment of arterial hypertensive disease with diuretics: V. Spironolactone, an aldosterone antagonist. Arch Intern Med 119:225-231, 1967.
13. Wolf RL, et al: Treatment of hypertension with spironolactone: Double-blind study. JAMA 198:1143-1149, 1966.
14. Crane MG, Harris JJ: Effect of spironolactone in hypertensive patients. Am J Med Sci 260:311-330, 1970.
15. Spark RF, Melby JC: Aldosteronism in hypertension: The spironolactone response test. Ann Intern Med 69:685-691, 1968.
16. Manning RT, Behrle FC: Use of spironolactone in renal edema: Effectiveness and association with hyperkalemia. JAMA 176:769-771, 1961.
17. Farland M, Pullman TN: Electrolyte complications of drug therapy. Med Clin North Am 47:113-129, 1963.
18. Herman E, Rado J: Fatal hyperkalemic paralysis associated with spironolactone. Arch Neurol 15:74-77, 1966.
19. Sjoberg WE, Kreisle JE: Hyperkalemia and sudden death during spironolactone (Aldactone) therapy. Tex State J Med 58:1022-1024, 1962.
20. Mann NM: Gynecomastia during therapy with spironolactone. JAMA 184:778-780, 1963.
21. Clark E: Spironolactone therapy and gynecomastia. JAMA 193:163-164, 1965.
22. Levitt JI: Spironolactone therapy and amenorrhea. JAMA 211:2014-2015, 1970.